Literature DB >> 12975683

Does the medicating ADHD increase or decrease the risk for later substance abuse?

Timothy E Wilens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12975683     DOI： 10.1590/s1516-44462003000300001

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN： 1516-4446            Impact factor:   2.697


× No keyword cloud information.
  9 in total

Review 1.  Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.

Authors:  Tobias Banaschewski; David Coghill; Paramala Santosh; Alessandro Zuddas; Philip Asherson; Jan Buitelaar; Marina Danckaerts; Manfred Döpfner; Stephen V Faraone; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Edmund J S Sonuga-Barke; Eric Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-05       Impact factor: 4.785

Review 2.  Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

Authors:  Steve S Lee; Kathryn L Humphreys; Kate Flory; Rebecca Liu; Kerrie Glass
Journal:  Clin Psychol Rev       Date:  2011-01-20

Review 3.  The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.

Authors:  Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule
Journal:  J Child Adolesc Psychopharmacol       Date:  2022-05-04       Impact factor: 3.031

Review 4.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

5.  Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.

Authors:  Maxim Lemelin; Takoua Boukhris; Jin-Ping Zhao; Odile Sheehy; Anick Bérard
Journal:  Pharmacol Res Perspect       Date:  2021-05

6.  High Trait Attention Promotes Resilience and Reduces Binge Drinking Among College Students With a Family History of Alcohol Use Disorder.

Authors:  Amanda Elton; J Hunter Allen; Mya Yorke; Farhan Khan; Qiaosen Lin; Charlotte A Boettiger
Journal:  Front Psychiatry       Date:  2021-05-13       Impact factor: 4.157

Review 7.  The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies.

Authors:  Susan J Young; Marios Adamou; Blanca Bolea; Gisli Gudjonsson; Ulrich Müller; Mark Pitts; Johannes Thome; Philip Asherson
Journal:  BMC Psychiatry       Date:  2011-02-18       Impact factor: 3.630

8.  The association between attention-deficit/hyperactivity disorder and early-onset alcohol dependence: A retrospective study.

Authors:  Sujaya Kumara R Sringeri; Ravi Philip Rajkumar; Kesavan Muralidharan; Channapatna R Chandrashekar; Vivek Benegal
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

9.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.